QIAGEN offers solutions from sample to result for oncology, infectious disease and transplantation testing, detection of latent tuberculosis infection and sexually transmitted diseases.

At QIAGEN, we strive for products that enable private and public facilities, hospitals and community clinics, and pathology and immunology labs to provide efficient and reliable diagnoses for patients based on clinical value.

More and more oncology treatments require molecular evaluation of biomarkers either for drug prescription or treatment follow-up. Find out about our therascreen and ipsogen diagnostic assays for KRAS, EGFR, BRAF, NRAS, JAK2, BCR-ABL1, and many other biomarkers. Learn about QIAGEN technologies for mutation detection, gene expression analysis, and other topics related to oncology and companion diagnostics.

Discover more about our solutions for the detection of tuberculosis infection. Two different technologies – measurement of cell-mediated immune responses by T-lymphocytes and PCR assays – cover all of your clinical needs.
​

QIAGEN's integrated solutions provide the highest medical value to clinicians and patients. By incorporating new approaches to immune monitoring to existing leading nucleic acid testing, we enable valuable insights to individualize the management of transplant recipients and enable greater care.